Diluted EPS came in at $-3.21, missed the $-0.05 consensus by $3.16.
Trailing eight quarters through Q1 2025
Common questions about Tevogen Bio Holdings, Inc.'s Q1 2025 earnings report.
Tevogen Bio Holdings, Inc. (TVGN) reported Q1 2025 earnings on May 14, 2025.
Tevogen Bio Holdings, Inc. reported diluted EPS of $-3.21 for Q1 2025.
EPS missed the consensus estimate of $-0.05 by $3.16.
You can read the 10-K periodic report (0001641172-25-002426) directly on SEC EDGAR. The filing index links above go to sec.gov.